Clinical characteristics and pharmacological management of COVID-19 vaccine–induced immune thrombotic thrombocytopenia with cerebral venous sinus …

JG Rizk, A Gupta, P Sardar, BM Henry… - JAMA …, 2021 - jamanetwork.com
Importance The COVID-19 pandemic saw one of the fastest developments of vaccines in an
effort to combat an out-of-control pandemic. The 2 most common COVID-19 vaccine
platforms currently in use, messenger RNA (mRNA) and adenovirus vector, were developed
on the basis of previous research in use of this technology. Postauthorization surveillance of
COVID-19 vaccines has identified safety signals, including unusual cases of
thrombocytopenia with thrombosis reported in recipients of adenoviral vector vaccines. One …